Announcement PDF ASX ANNOUNCEMENT 15 January 2016 RECCE Trade Mark Registered Recce Ltd is pleased to announce that: (a) Following the Company’s application, its Trade Mark RECCE has been accepted, and is thus registered in Australia. (b) Applications have been submitted additionally, for protection, in Europe, USA, Japan and China. (c) The applications include considerations of the foreign language aspects of the RECCE Trade Mark. RECCE® antibiotics are protected by patents in the above countries, representing around 80% of the world pharmaceutical market. For further information please visit www.recce.com.au or contact: Investor Relations Peter Williams CFO & Company Secretary Recce Ltd Tel: +61 8 9253 9800 Media Communication Karen Oswald – karen.oswald@markocommunications.com.au Gary Buchholz – gary@markocommunications.com.au Marko Communications Tel: +61 423 602 353 About Recce Ltd Recce Ltd (ASX: RCE), led by Dr Graham Melrose, is a world-leader in synthetic-polymer antibiotics. RECCE® antibiotics have been synthesised by an extremely simple and economic method. RECCE® antibiotics have shown in laboratory tests that they have continued activity against bacteria including superbugs, even after repeated use. Recce is positioned to achieve milestones in both pre-clinical trials for FDA purposes and the development of a pilot plant for flow-system manufacture of RECCE® antibiotics - that should drive significant value for the Company.